Over the years, researchers have made significant leaps in how we identify, treat, and manage neurological disorders – but in the past decade, these leaps have accelerated exponentially.
At LVIS Corp, we’re driven by a passion for innovation and solving complex neurological challenges. Our team is in the midst of redefining the landscape of diagnosis and treatment through our advanced neural information analysis tool, NeuroMatch®.
NeuroMatch® is an advanced digital medical device platform designed to assist in diagnosing neurological conditions through EEG signal viewing and analysis tools that decode brain networks and provide 3D/4D visualizations. Using near real-time data and sophisticated algorithms, it monitors neural pathways in the brain, allowing healthcare professionals to provide more accurate, individualized treatments for patients.
This technology not only improves patient outcomes but also streamlines analysis of patient data, making it a valuable tool for delivering superior neurological care.
As of 2024, this groundbreaking platform has been successfully installed in 10 prominent hospitals across South Korea. This marks a major step forward in advancing patient care and clinical outcomes in neurology – locally and globally.
In this blog, we want to explore the impact of NeuroMatch® and how this expansion will enhance healthcare delivery in South Korea.
About LVIS Corp: Who Are We?
Founded with a mission to revolutionize medical technology, LVIS Corp has consistently pushed the boundaries of what is possible in neurology and patient care. We specialize in innovative digital medical solutions, and we have a strong focus on creating technology that supports both healthcare professionals and patients alike.
With a history of successful medical technologies, LVIS Corp continues to redefine the future of neurological treatment and patient outcomes around the world.
Key Achievements and Milestones
LVIS Corp’s portfolio includes numerous advances in patient care technologies. From our inception, we have partnered with leading medical institutions worldwide to develop and deploy cutting-edge medical devices.
Some of our most notable achievements include collaborative projects in North America, and Asia, contributing to the continuous improvement of neurological patient care.
NeuroMatch® Installation in South Korean Hospitals
The installation of NeuroMatch® technology in 10 of South Korea’s top hospitals represents a major achievement for LVIS Corp. These institutions are recognized as leaders in the country’s healthcare system, known for their advanced medical services and research capabilities.
The hospitals include:
- Samsung Medical Center
- Seoul National University Hospital
- Asan Medical Center
- Yonsei University Hospital
- Keimyung University Dongsan Hospital
- Kyungpook University Hospital
- Yeungnam University Hospital
- Fatima Hospital
- Daegu Catholic Hospital
- Daegu Medical Center
Each of these facilities plays a crucial role in South Korea’s healthcare infrastructure. By adopting NeuroMatch® technology, they are now at the forefront of transforming neurological care in the country.
Why This is a Big Step Forward
Recent data from the World Health Organization indicates that over 1 in 3 people are affected by neurological conditions globally. This makes neurological disorders the leading cause of illness and disability worldwide.
Fortunately, our diagnosis and treatment abilities are improving immeasurably.
For LVIS Corp, the successful installation of NeuroMatch® in South Korea signals the beginning of broader international expansion. This milestone positions our company as a leader in global healthcare innovation, opening the door for further partnerships and installations worldwide.
With a proven track record in South Korea, LVIS Corp is poised to bring its groundbreaking technologies to new markets and enhance healthcare on a global scale.
As a South Korea-born Female scientist, our founder Dr. Lee Jin Hyung couldn’t be prouder to see LVIS’s technology embraced South Korea, and she looks forward to seeing more facilities embrace NeuroMatch® globally in the future.
Learn More About LVIS & NeuroMatch®
As NeuroMatch® continues to prove its value in enhancing patient outcomes and hospital efficiency, LVIS Corp remains dedicated to shaping the future of neurology and improving the quality of life for patients worldwide.
Interested in exploring a career with our team? Want to learn more about our technology? Get in touch with our U.S. branch today.